SEC Form 5 · accession 0001209191-16-098169
Q Therapeutics, Inc. · [NONE]
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven John Borst
Officer — Chief Executive Officer · Director
Period of report
Dec 31, 2015
Accepted (ET)
Feb 12, 2016 · 5:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001366541
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 31, 2015 | G | 10,500 | — | A | 511,806 | I | Shares are held by Mr. Borst's spouse. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares received as a gift.